|
Q1 2021
Filed on May 11, 2021
|
4,500
|
N/A
|
|
|
Q1 2021
Filed on May 11, 2021
|
315
|
$35.03 - $56.99
$11K - $18K
|
|
|
Q1 2021
Filed on May 11, 2021
|
857
|
$65.61 - $71.26
$56.2K - $61.1K
|
|
|
Q1 2021
Filed on May 11, 2021
|
50
|
$518.59 - $619.89
$25.9K - $31K
|
|
|
Q1 2021
Filed on May 11, 2021
|
651
|
$70.64 - $79.69
$46K - $51.9K
|
|
|
Q1 2021
Filed on May 11, 2021
|
500
|
N/A
|
|
|
Q1 2021
Filed on May 11, 2021
|
500
|
$13.31 - $16.54
$6.66K - $8.27K
|
|
|
Q1 2021
Filed on May 11, 2021
|
85
|
$84.79 - $104.74
$7.21K - $8.9K
|
|
|
Q1 2021
Filed on May 11, 2021
|
1,500
|
$6.02 - $8.06
$9.03K - $12.1K
|
|
|
Q1 2021
Filed on May 11, 2021
|
3,424
|
$8.58 - $9.57
$29.4K - $32.8K
|
|
Helius Med Technologies Inc Com Cl A New
|
Q1 2021
Filed on May 11, 2021
|
3,774
|
N/A
|
|
|
Q1 2021
Filed on May 11, 2021
|
33
|
$25.01 - $40.24
$825 - $1.33K
|
|
|
Q1 2021
Filed on May 11, 2021
|
5,639
|
$48.87 - $57.24
$276K - $323K
|
|
|
Q4 2020
Filed on Feb 09, 2021
|
146
|
N/A
|
|
Pivotal Invt Corp Ii Com Cl A
|
Q4 2020
Filed on Feb 09, 2021
|
500
|
N/A
|
|
|
Q4 2020
Filed on Feb 09, 2021
|
200
|
$22.2 - $32.43
$4.44K - $6.49K
|
|
|
Q4 2020
Filed on Feb 09, 2021
|
3,500
|
N/A
|
|
|
Q4 2020
Filed on Feb 09, 2021
|
600
|
$64.95 - $78.82
$39K - $47.3K
|
|
Ishares Ibonds Dec 2020 Term Corporate ETF
|
Q4 2020
Filed on Feb 09, 2021
|
45,291
|
N/A
|
|
|
Q4 2020
Filed on Feb 09, 2021
|
375
|
$34.48 - $44.59
$12.9K - $16.7K
|
|
|
Q4 2020
Filed on Feb 09, 2021
|
239
|
N/A
|
|
|
Q4 2020
Filed on Feb 09, 2021
|
500
|
$112.16 - $174.14
$56.1K - $87.1K
|
|
Gci Liberty Inc Com Class A
|
Q4 2020
Filed on Feb 09, 2021
|
268
|
N/A
|
|
|
Q4 2020
Filed on Feb 09, 2021
|
600
|
$19.23 - $28.37
$11.5K - $17K
|
|
|
Q3 2020
Filed on Oct 27, 2020
|
64
|
$381.58 - $427.77
$24.4K - $27.4K
|
|
|
Q3 2020
Filed on Oct 27, 2020
|
40,083
|
$32.11 - $36.44
$1.29M - $1.46M
|
|
|
Q3 2020
Filed on Oct 27, 2020
|
64,828
|
$32.5 - $36.82
$2.11M - $2.39M
|
|
|
Q3 2020
Filed on Oct 27, 2020
|
78
|
$517.69 - $633.05
$40.4K - $49.4K
|
|
Global X Scientific Beta Us ETF
|
Q3 2020
Filed on Oct 27, 2020
|
909
|
N/A
|
|
|
Q3 2020
Filed on Oct 27, 2020
|
26,199
|
$25.5 - $26.12
$668K - $684K
|
|
Bristol Myers Squibb CO Contngnt Val Rt
|
Q3 2020
Filed on Oct 27, 2020
|
398
|
N/A
|
|
|
Q3 2020
Filed on Oct 27, 2020
|
15
|
$1107.76 - $1250.35
$16.6K - $18.8K
|
|
|
Q3 2020
Filed on Oct 27, 2020
|
35
|
$26.0 - $30.01
$910 - $1.05K
|
|
|
Q3 2020
Filed on Oct 27, 2020
|
204
|
N/A
|
|
|
Q3 2020
Filed on Oct 27, 2020
|
49
|
$29.2 - $33.98
$1.43K - $1.67K
|
|
|
Q3 2020
Filed on Oct 27, 2020
|
45,154
|
$70.41 - $81.56
$3.18M - $3.68M
|
|
|
Q3 2020
Filed on Oct 27, 2020
|
121
|
$190.17 - $209.73
$23K - $25.4K
|
|
|
Q3 2020
Filed on Oct 27, 2020
|
51,368
|
$60.95 - $65.87
$3.13M - $3.38M
|
|
|
Q3 2020
Filed on Oct 27, 2020
|
11,609
|
$57.45 - $58.28
$667K - $677K
|
|
|
Q3 2020
Filed on Oct 27, 2020
|
23,426
|
$59.39 - $68.32
$1.39M - $1.6M
|
|
|
Q3 2020
Filed on Oct 27, 2020
|
43
|
$386.25 - $453.18
$16.6K - $19.5K
|
|
|
Q3 2020
Filed on Oct 27, 2020
|
348
|
$76.18 - $86.84
$26.5K - $30.2K
|
|
|
Q3 2020
Filed on Oct 27, 2020
|
10,000
|
$143.34 - $162.04
$1.43M - $1.62M
|
|
|
Q3 2020
Filed on Oct 27, 2020
|
6,282
|
$318.46 - $358.67
$2M - $2.25M
|
|
|
Q3 2020
Filed on Oct 27, 2020
|
32,200
|
N/A
|
|
|
Q3 2020
Filed on Oct 27, 2020
|
2
|
N/A
|
|
|
Q3 2020
Filed on Oct 27, 2020
|
9,000
|
$166.29 - $188.98
$1.5M - $1.7M
|
|
|
Q3 2020
Filed on Oct 27, 2020
|
205
|
$69.47 - $84.67
$14.2K - $17.4K
|
|
|
Q3 2020
Filed on Oct 27, 2020
|
75
|
$268.51 - $400.74
$20.1K - $30.1K
|
|
|
Q3 2020
Filed on Oct 27, 2020
|
151
|
$135.48 - $155.76
$20.5K - $23.5K
|
|